Investigations on a clinically and functionally unusual and novel germline p53 mutation

Autor: Graham R. Taylor, Ruth Charlton, Diana M. Barnes, Richard Camplejohn, Xin Lu, C E Chu, P M Duddy, J Rutherford, P Chumas
Rok vydání: 2002
Předmět:
p53
Cancer Research
DNA Mutational Analysis
Apoptosis
medicine.disease_cause
Germline
Exon
Mutant protein
Tumor Cells
Cultured

Lymphocytes
Frameshift Mutation
Tumor Stem Cell Assay
Osteosarcoma
Mutation
Li Fraumeni
Neoplasms
Second Primary

DNA
Neoplasm

Exons
Neoplasm Proteins
Pedigree
Oncology
Codon
Nonsense

Female
Choroid plexus
Adult
Transcriptional Activation
Choroid Plexus Neoplasms
Recombinant Fusion Proteins
Molecular Sequence Data
Bone Neoplasms
Saccharomyces cerevisiae
Biology
Transfection
Frameshift mutation
Germline mutation
medicine
Humans
Genetic Predisposition to Disease
Gene
Alleles
Germ-Line Mutation
choroid plexus
Base Sequence
Papilloma
Genetics and Genomics
Genes
p53

Molecular biology
Mutagenesis
Insertional

Amino Acid Substitution
Cancer research
Tumor Suppressor Protein p53
Zdroj: British Journal of Cancer
ISSN: 1532-1827
0007-0920
DOI: 10.1038/sj.bjc.6600269
Popis: This report describes an individual with a rare choroid plexus papilloma in adulthood (age 29) after earlier having an osteosarcoma (age 22). The results from this study, and others, suggest that it may be advisable to consider the possibility of a germline p53 mutation in adults presenting with choroid plexus tumours. In the current study automated DNA sequencing of genomic DNA detected a novel germline 7 base pair insertion in exon 5 of the p53 gene in this patient. The alteration in frame would produce amino acid substitutions beginning with alanine to glycine at position 161 and a stop codon at position 182 in the mutated protein. Surprisingly two assays of p53 function gave apparently wild-type results on peripheral blood lymphocytes from this individual. These results led us to carry out more detailed functional tests on the mutant protein. The mutant allele was expressed either at very low levels or not at all in phytohaemagglutinin stimulated lymphocytes. Further, the mutant protein was completely non-functional in terms of its ability to transactivate a series of p53-responsive genes (p21WAF1, bax, PIG3), to transrepress a target gene and to inhibit colony growth in transfected Saos-2 cells. However, surprisingly, data from irradiated peripheral blood lymphocytes and transfected Saos-2 cells, suggested that this truncated, mutant protein retains significant ability to induce apoptosis. British Journal of Cancer (2002) 86, 1592–1596. DOI: 10.1038/sj/bjc/6600269 www.bjcancer.com © 2002 Cancer Research UK
Databáze: OpenAIRE